Jablecka A - Search Results

1

Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity.

Bogdanski P, Suliburska J, Grabanska K, Musialik K, Cieslewicz A, Skoluda A, Jablecka A. Bogdanski P, et al. Among authors: jablecka a. Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):816-23. Eur Rev Med Pharmacol Sci. 2012. PMID: 22913215 Clinical Trial.

2

[Evaluation of selected acute phase proteins in patients with metabolic syndrome].

Bogdański P, Chyrek R, Pupek-Musialik D, Jabłecka A. Bogdański P, et al. Among authors: jablecka a. Pol Merkur Lekarski. 2006 Jul;21(121):12-4. Pol Merkur Lekarski. 2006. PMID: 17007284 Polish.

3

Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus.

Bogdanski P, Pupek-Musialik D, Dytfeld J, Jagodzinski PP, Jablecka A, Kujawa A, Musialik K. Bogdanski P, et al. Among authors: jablecka a. Int J Clin Pharmacol Ther. 2007 Oct;45(10):563-7. doi: 10.5414/cpp45563. Int J Clin Pharmacol Ther. 2007. PMID: 17966842 Clinical Trial.

4

Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients.

Bogdanski P, Pupek-Musialik D, Dytfeld J, Lacinski M, Jablecka A, Jakubowski H. Bogdanski P, et al. Among authors: jablecka a. Biomed Pharmacother. 2008 Jul-Aug;62(6):360-5. doi: 10.1016/j.biopha.2007.10.019. Epub 2007 Dec 3. Biomed Pharmacother. 2008. PMID: 18093792 Clinical Trial.

5

Influence of L-arginine on the nitric oxide concentration and level of oxidative stress during ischemia-reperfusion injury in a rat model.

Krauss H, Jablecka A, Sosnowski P, Bogdanski P. Krauss H, et al. Among authors: jablecka a. Int J Clin Pharmacol Ther. 2009 Aug;47(8):533-8. doi: 10.5414/cpp47533. Int J Clin Pharmacol Ther. 2009. PMID: 19640362

6

Influence of selected angiotensin-converting enzyme inhibitors on alloxan-induced diabetic cataract in rabbits.

Jablecka A, Czaplicka E, Olszewski J, Bogdanski P, Krauss H, Smolarek I. Jablecka A, et al. Med Sci Monit. 2009 Nov;15(11):BR334-8. Med Sci Monit. 2009. PMID: 19865050

7

Neopterin as a prognostic marker in patients with chronic heart failure.

Wietlicka-Kokoszanek I, Jablecka A, Smolarek I, Bogdanski P, Chmara E, Korzeniowska K, Kazmierczak M, Kazmierczak E, Musialik K. Wietlicka-Kokoszanek I, et al. Among authors: jablecka a. Med Sci Monit. 2010 May;16(5):CR232-7. Med Sci Monit. 2010. PMID: 20424550

8

Evaluation of the antihypertensive effect of L-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring.

Ast J, Jablecka A, Bogdanski P, Smolarek I, Krauss H, Chmara E. Ast J, et al. Among authors: jablecka a. Med Sci Monit. 2010 May;16(5):CR266-71. Med Sci Monit. 2010. PMID: 20424555 Clinical Trial.

9

[The assessment of neopterin concentration in patients with heart failure].

Wetlicka I, Korzeniowska K, Bogdański P, Kazmierczak M, Chmara E, Musialik K, Jabłecka A. Wetlicka I, et al. Among authors: jablecka a. Pol Merkur Lekarski. 2010 Apr;28(166):256-9. Pol Merkur Lekarski. 2010. PMID: 20491332 Polish.

10

[Influence of regular physical activity on oxidative stress in women with simple obesity].

Hen K, Bogdański P, Szulińska M, Jabłecka A, Pupek-Musialik D. Hen K, et al. Among authors: jablecka a. Pol Merkur Lekarski. 2010 Apr;28(166):284-8. Pol Merkur Lekarski. 2010. PMID: 20491338 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters